检索结果-南通市图书馆

Atrophy of the left dorsolateral prefrontal cortex is associated with poor performance in verbal fluency in elderly poststroke women

引用

Neural Regeneration Research 2013年第4期8卷 346-356页

作者： Yang-Kun Chen Wei-Min Xiao Defeng Wang Lin Shi Winnie CW Chu Vincent CT Mok Ka Sing Wong Gabor S Ungvari Wai Kwong Tang Department of Neurology Dongguan People's Hospital Department of Diagnostic Radiology and Organ Imaging the Chinese University of Hong Kong Department of Medicine and Therapeutics the Chinese University of Hong Kong graylands hospital School of Psychiatry & Clinical NeurosciencesUniversity of Western AustraliaPerth 6005Australia Department of Psychiatry the Chinese University of Hong Kong

This study aimed to investigate the association between atrophy in the prefrontal cortex with executive function and verbal fluency in elderly male and female patients poststroke. Thirty elderly female patients with non-aphasic ischemic stroke aged -〉 60 years and 30 age-matched non-aphasic male patients with ischemic stroke were recruited. Automatic magnetic resonance imaging segmentation was used to assess the volume of the whole prefrontal cortex, along with its subdivisions： anterior cingulate cortex, orbitofrontal cortex and dorsolateral prefrontal cortex. The Semantic Verbal Fluency Test was administered at 3 and 15 months poststroke. At 3 months poststroke, left dorsolateral prefrontal cortex volume was significantly correlated with Verbal Fluency Test score in female patients only （partial coefficient = 0.453, P = 0.045）, after controlling for age, education, diabetes, neurological deficit, white matter lesions volume, as well as the location and volume of infarcts. At 15 months poststroke, there remained a significant association between the left dorsolateral prefrontal cortex volume and Verbal Fluency Test （partial coefficient = 0.661, P = 0.001） and between the left prefrontal cortex volume and Verbal Fluency Test （partial coefficient = 0.573, P = 0.004） in female patients after the same adjustments. These findings indicate that atrophy of the left dorsolateral prefrontal cortex contributes to the impairment of verbal fluency in elderly female patients with stroke. Sex differences may be present in the neuropsychological mechanisms of verbal fluency impairment in patients with stroke.

关键词： neural regeneration neuroimaging brain atrophy verbal fluency executive function stroke sex differences prefrontal cortex dorsolateral prefrontal cortex magnetic resonance imaging grants-supported paper photographs-containing paper neuroregeneration

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Sleep dysfunctions in schizophrenia: A practical review

引用

Open Journal of Psychiatry 2012年第4期2卷 384-392页

作者： Flavie Waters Dara S. Manoach Centre for Clinical Research in Neuropsychiatry Graylands Hospital North Metro Area Mental Health Perth Australia Department of Psychiatry Massachusetts General Hospital Charlestown USA

Objective: Sleep dysfunctions are common in schizophrenia, yet few evidence-based guidelines exist for the detection, diagnosis and management of sleep disturbances in this disorder. This critical review paper sought to increase awareness amongst mental health clinicians of sleep problems in schizophrenia, promote better identification of sleep problems, and help clinicians make more informed decisions about integrated treatment plans. Specifically, we examined the following key questions: 1) Which sleep problems occur in schizophrenia? 2) What evidence exists regarding the impact of poor sleep? 3) What are the underlying mechanisms of sleep problems in schizophrenia? 4) How can this information be used by clinicians to design a more complete treatment plan? Data Sources and study selection: We conducted a non-systematic review of studies that have shaped our current understanding of sleep in schizophrenia (n = 65). Data sources included PubMed, Medline, and cross-referencing. Results: Sleep disorders are pervasive and broad-ranging in people with schizophrenia, and are associated with substantial burden. An integrated model is proposed whereby a combination of highly interactive factors comprising genetic and neurobiological vulnerabilities, and behavioural and environmental factors, interact to cause sleep abnormalities. However, prospective and rigorous studies of sleep in schizophrenia are lacking. Conclusion: Patients often do not receive optimal care because sleep problems are rarely diagnosed, and treatments plans are incompletely formulated. A better understanding of sleep problems in schizophrenia will lead to increased treatment options, and a more positive clinical outcome.

关键词： Circadian Sleep Wake Medication PSG Spindles Cognition OSA

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

对精神分裂症患者血脂异常的瑞舒伐他汀辅助治疗的疗效与安全性的的Meta分析（英文）

引用

上海精神医学 2018年第1期30卷 4-11页

作者：郑伟杨威张庆娥杨欣湖蔡东滨胡晋卿 Ungvari.GS HN Chee Hert MD 宁玉萍项玉涛 The Affiliated Brain hospital of Guangzhou Medical University (Guangzhou Huiai hospital) Guangzhou China Xiamen Xian Yue hospital Xiamen Fujian China The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders Beijing Anding Hospital Capital Medical University Beijing China Clinics of Chinese Medicine the First Clinical Medical College of Guangzhou University of Chinese Medicine Guangzhou China The University of Notre Dame Australia / Marian Centre & graylands hospital Perth Australia Department of Psychiatry University of Melbourne Melbourne Victoria Australia Universitair Psychiatrisch Centrum KU Leuven Leuven Belgium Department of Neurosciences KU Leuven Belgium Unit of Psychiatry Faculty of Health Sciences University of Macao Macao SAR China

背景:精神分裂症患者的代谢综合征是一个重要的健康问题。瑞舒伐他汀对血脂异常的辅助性治疗的有效性和安全性存在争议。目的:评价瑞舒伐他汀对精神分裂症患者血脂异常的辅助性治疗的有效性和安全性。方法:我们从以下数据库中系统地检索... 详细信息

背景:精神分裂症患者的代谢综合征是一个重要的健康问题。瑞舒伐他汀对血脂异常的辅助性治疗的有效性和安全性存在争议。目的:评价瑞舒伐他汀对精神分裂症患者血脂异常的辅助性治疗的有效性和安全性。方法:我们从以下数据库中系统地检索了2017年9月28日以前相关的临床对照试验:Pub Med、Psyc INFO、Cochrane图书馆、中国知网、万方数据库、中国生物医学文献数据库。我们计算了标准平均差(SMD)、风险比(RR)及其95%的可信区间(CIs)。使用偏移评估工具中的Cochrane风险评估来评价所纳入研究的质量。并采用GRADE系统推荐的等级方法(推荐、评估、发展、评价的等级)作为参照标准。结果:确认和分析了4项比较瑞舒伐他汀组(n=138)和对照组(n=136)的研究(n=274)。瑞舒伐他汀辅助治疗显示对低密度脂蛋白胆固醇(LDL-C)[4项试验,n=272,SMD:-1.31(95%CI:-1.93,-0.70),I^2=81%]、总胆固醇(2项试验,n=164,SMD:-2.00(95%CI:-2.79,-1.21);I^2=76%)、和甘油三酯(2项试验,n=164,SMD:-1.05(95%CI:-1.38,-0.72);I^2=0%)的疗效比对照组更有效,但对高密度脂蛋白胆固醇(2项试验,n=164,SMD:0.14(95%CI:-0.16,0.45);I^2=0%)的疗效没有显著差异。去除一项没有随机试验的LDL-C研究之后,显著差异仍然存在[3项试验,n=172,SMD:-1.07(95%CI:-1.60,-0.53);I^2=63%]。体重(3项试验,n=208,SMD:-0.40(95%CI:-1.29,0.49);I^2=89%)、身体质量指数(2项试验,n=164,SMD:-0.34(95%CI:-1.23,0.56);I^2=87%)、腰围(3项试验,n=208,SMD:-0.43(95%CI:-1.31,0.46);I^2=89%)、空腹血糖(4项试验,n=272,SMD:-0.25(95%CI:-0.65,0.15);I^2=62%)方面组间没有显著的差异。两组之间的不良反应及停药率相近。根据GRADE分级方法,主要结果的证据水平低被评为"非常低"(35.3%)到"低"(64.7%)。其中,主要结果(LDL-C)被评为"非常低"。结论:对精神分裂症患者血脂异常的瑞舒伐他汀辅助性治疗的现有数据尚不足以对其有效性和安全性做出明确的解释。需进一步针对高质量的延长治疗时间的随机对照试验来验证该结论。

关键词：精神分裂症瑞舒伐他汀血脂异常低密度脂蛋白胆固醇 Meta分析

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：